EE526 Public Health Impact and Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.767
https://www.valueinhealthjournal.com/article/S1098-3015(22)02971-0/fulltext
Title :
EE526 Public Health Impact and Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02971-0&doi=10.1016/j.jval.2022.09.767
First page :
Section Title :
Open access? :
No
Section Order :
10306